<?xml version="1.0" encoding="UTF-8"?>
<!DOCTYPE article PUBLIC "-//NLM//DTD JATS (Z39.96) Journal Publishing DTD v1.3 20210610//EN" "JATS-journalpublishing1-3.dtd">
<article article-type="research-article" dtd-version="1.3" xmlns:mml="http://www.w3.org/1998/Math/MathML" xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:xsi="http://www.w3.org/2001/XMLSchema-instance" xml:lang="ru"><front><journal-meta><journal-id journal-id-type="publisher-id">mimmun</journal-id><journal-title-group><journal-title xml:lang="ru">Медицинская иммунология</journal-title><trans-title-group xml:lang="en"><trans-title>Medical Immunology (Russia)</trans-title></trans-title-group></journal-title-group><issn pub-type="ppub">1563-0625</issn><issn pub-type="epub">2313-741X</issn><publisher><publisher-name>SPb RAACI</publisher-name></publisher></journal-meta><article-meta><article-id pub-id-type="doi">10.15789/1563-0625-2010-4-5-285-296</article-id><article-id custom-type="elpub" pub-id-type="custom">mimmun-125</article-id><article-categories><subj-group subj-group-type="heading"><subject>Research Article</subject></subj-group><subj-group subj-group-type="section-heading" xml:lang="ru"><subject>ОБЗОРЫ</subject></subj-group><subj-group subj-group-type="section-heading" xml:lang="en"><subject>REVIEWS</subject></subj-group></article-categories><title-group><article-title>КЛЕТОЧНЫЙ ГЕНОМ В ПАТОГЕНЕЗЕ ОСНОВНЫХ ЗАБОЛЕВАНИЙ ЧЕЛОВЕКА (АТЕРОСКЛЕРОЗ, АУТОИММУННЫЕ ЗАБОЛЕВАНИЯ, РАК)</article-title><trans-title-group xml:lang="en"><trans-title>CELLULAR GENOME IN PATHOGENESIS OF BASIC DISEASES IN HUMANS (ATHEROSCLEROSIS,  AUTOIMMUNE DISEASES, CANCER)</trans-title></trans-title-group></title-group><contrib-group><contrib contrib-type="author" corresp="yes"><name-alternatives><name name-style="eastern" xml:lang="ru"><surname>Козлов</surname><given-names>В. А.</given-names></name><name name-style="western" xml:lang="en"><surname>Kozlov</surname><given-names>V. A.</given-names></name></name-alternatives><email xlink:type="simple">v_kozlov@online.nsk.su</email><xref ref-type="aff" rid="aff-1"/></contrib></contrib-group><aff-alternatives id="aff-1"><aff xml:lang="ru">НИИ клинической иммунологии СО РАМН, г. Новосибирск<country>Россия</country></aff></aff-alternatives><pub-date pub-type="collection"><year>2010</year></pub-date><pub-date pub-type="epub"><day>16</day><month>07</month><year>2014</year></pub-date><volume>12</volume><issue>4-5</issue><fpage>285</fpage><lpage>296</lpage><permissions><copyright-statement>Copyright &amp;#x00A9; Козлов В.А., 2014</copyright-statement><copyright-year>2014</copyright-year><copyright-holder xml:lang="ru">Козлов В.А.</copyright-holder><copyright-holder xml:lang="en">Kozlov V.A.</copyright-holder><license license-type="creative-commons-attribution" xlink:href="https://creativecommons.org/licenses/by/4.0/" xlink:type="simple"><license-p>This work is licensed under a Creative Commons Attribution 4.0 License.</license-p></license></permissions><self-uri xlink:href="https://www.mimmun.ru/mimmun/article/view/125">https://www.mimmun.ru/mimmun/article/view/125</self-uri><abstract/><trans-abstract xml:lang="en"/><kwd-group xml:lang="ru"><kwd>геном</kwd><kwd>метилирование</kwd><kwd>теломеры</kwd><kwd>атеросклероз</kwd><kwd>рак</kwd></kwd-group><kwd-group xml:lang="en"><kwd>genome</kwd><kwd>methylation</kwd><kwd>atherosclerosis</kwd><kwd>telomere</kwd><kwd>cancer</kwd></kwd-group></article-meta></front><back><ref-list><title>References</title><ref id="cit1"><label>1</label><citation-alternatives><mixed-citation xml:lang="ru">Борисов В.И., Кожевников В.С., Сенюков В.В., Сизиков А.Э., Коненкова Л.П., Герцог О.А., Козлов В.А. Укорочение длины теломер моноцитов при ревматоидном артрите//Медицинская иммунология. -2006. -Т. 1. -С. 87-90.</mixed-citation><mixed-citation xml:lang="en">Борисов В.И., Кожевников В.С., Сенюков В.В., Сизиков А.Э., Коненкова Л.П., Герцог О.А., Козлов В.А. Укорочение длины теломер моноцитов при ревматоидном артрите//Медицинская иммунология. -2006. -Т. 1. -С. 87-90.</mixed-citation></citation-alternatives></ref><ref id="cit2"><label>2</label><citation-alternatives><mixed-citation xml:lang="ru">Патрушев Л.И. Экспрессия генов. -Москва: Наука, 2000.</mixed-citation><mixed-citation xml:lang="en">Патрушев Л.И. Экспрессия генов. -Москва: Наука, 2000.</mixed-citation></citation-alternatives></ref><ref id="cit3"><label>3</label><citation-alternatives><mixed-citation xml:lang="ru">Bailey S.M., Murnane J.P. Telomeres, chromosome instability and cancer//Nucleic Acids Res. -2006. -Vol. 34, N 8. -P. 2408-2417.</mixed-citation><mixed-citation xml:lang="en">Bailey S.M., Murnane J.P. Telomeres, chromosome instability and cancer//Nucleic Acids Res. -2006. -Vol. 34, N 8. -P. 2408-2417.</mixed-citation></citation-alternatives></ref><ref id="cit4"><label>4</label><citation-alternatives><mixed-citation xml:lang="ru">Ballestar E., Esteller M., Richardson B.C. The epigenetic face of systemic lupus erythematosus//J. Immunol. -2006. -Vol. 176, N 12. -P. 7143-7147.</mixed-citation><mixed-citation xml:lang="en">Ballestar E., Esteller M., Richardson B.C. The epigenetic face of systemic lupus erythematosus//J. Immunol. -2006. -Vol. 176, N 12. -P. 7143-7147.</mixed-citation></citation-alternatives></ref><ref id="cit5"><label>5</label><citation-alternatives><mixed-citation xml:lang="ru">Benetos A., Gardner J.P., Zureik M., Labat C., Xiaobin L., Adamopoulos C., Temmar M., Bean K.E., Thomas F., Avitev A. Short telomeres are associated with increased carotid atherosclerosis in hypertensive subjects//Hypertension. -2004. -Vol. 43. -P. 182-185.</mixed-citation><mixed-citation xml:lang="en">Benetos A., Gardner J.P., Zureik M., Labat C., Xiaobin L., Adamopoulos C., Temmar M., Bean K.E., Thomas F., Avitev A. Short telomeres are associated with increased carotid atherosclerosis in hypertensive subjects//Hypertension. -2004. -Vol. 43. -P. 182-185.</mixed-citation></citation-alternatives></ref><ref id="cit6"><label>6</label><citation-alternatives><mixed-citation xml:lang="ru">Carpenter E.L., Vonderheide R.H. Telomerase-based immunitherapy of cancer//Expert Opin Biol Ther. -2006. -Vol. 6. -P. 1031-1039.</mixed-citation><mixed-citation xml:lang="en">Carpenter E.L., Vonderheide R.H. Telomerase-based immunitherapy of cancer//Expert Opin Biol Ther. -2006. -Vol. 6. -P. 1031-1039.</mixed-citation></citation-alternatives></ref><ref id="cit7"><label>7</label><citation-alternatives><mixed-citation xml:lang="ru">Colmegna I., Diaz-Borjon A., Fujii H., Schaefer L., Golonzy J.J., Weyand C.M. Defective proliferative capacity and accelerated telomeric loss of hematopoietic progenitor cells in rheumatoid arthritis//Arthritis Rheum. -2008. -Vol. 58, N 4. -P. 990-1000.</mixed-citation><mixed-citation xml:lang="en">Colmegna I., Diaz-Borjon A., Fujii H., Schaefer L., Golonzy J.J., Weyand C.M. Defective proliferative capacity and accelerated telomeric loss of hematopoietic progenitor cells in rheumatoid arthritis//Arthritis Rheum. -2008. -Vol. 58, N 4. -P. 990-1000.</mixed-citation></citation-alternatives></ref><ref id="cit8"><label>8</label><citation-alternatives><mixed-citation xml:lang="ru">Dikmen Z.G., Gellert G.C., Jackson, Gryaznov S., Tressler R., Dogan P., Wright W.E., Shay J.W. In vivo inhibition of lung cancer by GRN163L: a novel human telomerase inhibitor//Cancer Res. -2005. -Vol. 65, N 17. -P. 7866-7873.</mixed-citation><mixed-citation xml:lang="en">Dikmen Z.G., Gellert G.C., Jackson, Gryaznov S., Tressler R., Dogan P., Wright W.E., Shay J.W. In vivo inhibition of lung cancer by GRN163L: a novel human telomerase inhibitor//Cancer Res. -2005. -Vol. 65, N 17. -P. 7866-7873.</mixed-citation></citation-alternatives></ref><ref id="cit9"><label>9</label><citation-alternatives><mixed-citation xml:lang="ru">Dong C., Yoon W., Goldschimidt-Clermont P.J. DNA methylation and atherosclerosis//J. Nutr. -2002. -Vol. 132(8 suppl). -P. 2406S-2409S.</mixed-citation><mixed-citation xml:lang="en">Dong C., Yoon W., Goldschimidt-Clermont P.J. DNA methylation and atherosclerosis//J. Nutr. -2002. -Vol. 132(8 suppl). -P. 2406S-2409S.</mixed-citation></citation-alternatives></ref><ref id="cit10"><label>10</label><citation-alternatives><mixed-citation xml:lang="ru">Egger G., Liang G., Aparicio A., Jones P.A. Epigenetics in human disease and prospects for epigenetics therapy//Nature. -2004. -Vol. 429, N 6990. -P. 457-463.</mixed-citation><mixed-citation xml:lang="en">Egger G., Liang G., Aparicio A., Jones P.A. Epigenetics in human disease and prospects for epigenetics therapy//Nature. -2004. -Vol. 429, N 6990. -P. 457-463.</mixed-citation></citation-alternatives></ref><ref id="cit11"><label>11</label><citation-alternatives><mixed-citation xml:lang="ru">Feinberg A.P. Epigenetics at the epicenter of modern medicine//JAMA. -2008. -Vol. 299, N 11. -P. 1345-1350.</mixed-citation><mixed-citation xml:lang="en">Feinberg A.P. Epigenetics at the epicenter of modern medicine//JAMA. -2008. -Vol. 299, N 11. -P. 1345-1350.</mixed-citation></citation-alternatives></ref><ref id="cit12"><label>12</label><citation-alternatives><mixed-citation xml:lang="ru">Feltus F.A., Lee E.K., Costello J.F., Plass C., Vertino P.M. Predicting aberrant CpG island methylation//Proc. Natl. Acad. Sci. -2003. -Vol. 100, N 21. -P. 12253-12258.</mixed-citation><mixed-citation xml:lang="en">Feltus F.A., Lee E.K., Costello J.F., Plass C., Vertino P.M. Predicting aberrant CpG island methylation//Proc. Natl. Acad. Sci. -2003. -Vol. 100, N 21. -P. 12253-12258.</mixed-citation></citation-alternatives></ref><ref id="cit13"><label>13</label><citation-alternatives><mixed-citation xml:lang="ru">Fu L.H., Cong B., Zhen Y.F., Li S.J., Ma C.L., Ni Z.Y., Zhang G.Z., Zuo M., Yao Y.X. Methylation status of the IL-10 gene promoter in the peripheral blood mononuclear cells of rheumatoid arthritis patients//Yi Chuan. -2007. -Vol. 29, N 11. -P. 1357-1361.</mixed-citation><mixed-citation xml:lang="en">Fu L.H., Cong B., Zhen Y.F., Li S.J., Ma C.L., Ni Z.Y., Zhang G.Z., Zuo M., Yao Y.X. Methylation status of the IL-10 gene promoter in the peripheral blood mononuclear cells of rheumatoid arthritis patients//Yi Chuan. -2007. -Vol. 29, N 11. -P. 1357-1361.</mixed-citation></citation-alternatives></ref><ref id="cit14"><label>14</label><citation-alternatives><mixed-citation xml:lang="ru">Gellert G.C., Dikmen Z.G., Wright W.E., Gryasnov S., Shay J.W. Effects of novel telomerase inhibitor, GRN163L, in human breast cancer//Breast Cancer Res and Treatment. -2006. -Vol. 96, N 1. -P. 73-81.</mixed-citation><mixed-citation xml:lang="en">Gellert G.C., Dikmen Z.G., Wright W.E., Gryasnov S., Shay J.W. Effects of novel telomerase inhibitor, GRN163L, in human breast cancer//Breast Cancer Res and Treatment. -2006. -Vol. 96, N 1. -P. 73-81.</mixed-citation></citation-alternatives></ref><ref id="cit15"><label>15</label><citation-alternatives><mixed-citation xml:lang="ru">Hiltunen M.P., Hakkinen T.P., Rutanen J., Hedman M., Makinen K., Turunen A.M., Aalto-Setala K., Yia-Herttuala S. DNA hypomethylation and methyltransferase expression in atherosclerotic lesions//Vascular Medicine. -2002. -Vol. 7, N 1. -P. 1-11.</mixed-citation><mixed-citation xml:lang="en">Hiltunen M.P., Hakkinen T.P., Rutanen J., Hedman M., Makinen K., Turunen A.M., Aalto-Setala K., Yia-Herttuala S. DNA hypomethylation and methyltransferase expression in atherosclerotic lesions//Vascular Medicine. -2002. -Vol. 7, N 1. -P. 1-11.</mixed-citation></citation-alternatives></ref><ref id="cit16"><label>16</label><citation-alternatives><mixed-citation xml:lang="ru">Hiltunen M.O., Yla-Herttuala S. DNA methylation, smooth, muscle cells, and atherogenesis//Arteroscler Thromb. Vasc. Biol. -2003. -Vol. 23, N 10. -P. 1750-1753.</mixed-citation><mixed-citation xml:lang="en">Hiltunen M.O., Yla-Herttuala S. DNA methylation, smooth, muscle cells, and atherogenesis//Arteroscler Thromb. Vasc. Biol. -2003. -Vol. 23, N 10. -P. 1750-1753.</mixed-citation></citation-alternatives></ref><ref id="cit17"><label>17</label><citation-alternatives><mixed-citation xml:lang="ru">Honda M., Mengesha E., Albano S., Nichols W.S., Wallace D.J., Metzger A., Klinenberg J.R., Linker-Israeli M. Telomere shortening and decreased replicative potential, contrasted by continued prokiferation of telomerase-positive CD8+CD28(lo) T cells in patients with systemic lupus erythematosus//Clin. Immunol. -2001. -Vol. 99, N 2. -P. 211-221.</mixed-citation><mixed-citation xml:lang="en">Honda M., Mengesha E., Albano S., Nichols W.S., Wallace D.J., Metzger A., Klinenberg J.R., Linker-Israeli M. Telomere shortening and decreased replicative potential, contrasted by continued prokiferation of telomerase-positive CD8+CD28(lo) T cells in patients with systemic lupus erythematosus//Clin. Immunol. -2001. -Vol. 99, N 2. -P. 211-221.</mixed-citation></citation-alternatives></ref><ref id="cit18"><label>18</label><citation-alternatives><mixed-citation xml:lang="ru">Kanai Y. Alterations of DNA methylation and clinicopathological diversity of human cancer//Pathol. International. -2008. -Vol. 58. -P. 544-558.</mixed-citation><mixed-citation xml:lang="en">Kanai Y. Alterations of DNA methylation and clinicopathological diversity of human cancer//Pathol. International. -2008. -Vol. 58. -P. 544-558.</mixed-citation></citation-alternatives></ref><ref id="cit19"><label>19</label><citation-alternatives><mixed-citation xml:lang="ru">Kiyozuka Y., Yamamoto D., Yang J., Uemura Y., Senzaki H., Adachi S., Tsubura A. Correlation of chemosensitivity to anticancer drugs and telomere ength, telomerase activity and telomerase RNA expression in human ovarian cancer cells//Anticancer Res. -2000. -Vol. 20, N 1A. -P. 203-212.</mixed-citation><mixed-citation xml:lang="en">Kiyozuka Y., Yamamoto D., Yang J., Uemura Y., Senzaki H., Adachi S., Tsubura A. Correlation of chemosensitivity to anticancer drugs and telomere ength, telomerase activity and telomerase RNA expression in human ovarian cancer cells//Anticancer Res. -2000. -Vol. 20, N 1A. -P. 203-212.</mixed-citation></citation-alternatives></ref><ref id="cit20"><label>20</label><citation-alternatives><mixed-citation xml:lang="ru">Klapper W., Moosig F., Sotnikova A., Qian W., Schroder J.O., Parwaresch R. Telomerase activity in B and T lymphocytes of patients with systemic lupus erythematosus//Ann. Rheum. -2004. -Vol. 63. -P. 1681-1683.</mixed-citation><mixed-citation xml:lang="en">Klapper W., Moosig F., Sotnikova A., Qian W., Schroder J.O., Parwaresch R. Telomerase activity in B and T lymphocytes of patients with systemic lupus erythematosus//Ann. Rheum. -2004. -Vol. 63. -P. 1681-1683.</mixed-citation></citation-alternatives></ref><ref id="cit21"><label>21</label><citation-alternatives><mixed-citation xml:lang="ru">Kwon N.H., Kim J.S., Lee J.Y., Oh M.J., Choi D.C. DNA methylation and the expression of IL-4 and IFN gamma promoter genes in patients with bronchial asthma//J. Clin. Immunol. -2008. -Vol. 28, N 2. -P. 139-146.</mixed-citation><mixed-citation xml:lang="en">Kwon N.H., Kim J.S., Lee J.Y., Oh M.J., Choi D.C. DNA methylation and the expression of IL-4 and IFN gamma promoter genes in patients with bronchial asthma//J. Clin. Immunol. -2008. -Vol. 28, N 2. -P. 139-146.</mixed-citation></citation-alternatives></ref><ref id="cit22"><label>22</label><citation-alternatives><mixed-citation xml:lang="ru">Lee W.J., Kim H.J. Inhibition of DNA methylation is involved in transdifferentiation of myoblasts into muscle cells//Mol. Cells. -2007. -Vol. 24, N 3. -P. 441-444.</mixed-citation><mixed-citation xml:lang="en">Lee W.J., Kim H.J. Inhibition of DNA methylation is involved in transdifferentiation of myoblasts into muscle cells//Mol. Cells. -2007. -Vol. 24, N 3. -P. 441-444.</mixed-citation></citation-alternatives></ref><ref id="cit23"><label>23</label><citation-alternatives><mixed-citation xml:lang="ru">Li E. The mojo of methylation//Nat. Genet. -1999. -Vol. 23, N 1. -P. 5-6.</mixed-citation><mixed-citation xml:lang="en">Li E. The mojo of methylation//Nat. Genet. -1999. -Vol. 23, N 1. -P. 5-6.</mixed-citation></citation-alternatives></ref><ref id="cit24"><label>24</label><citation-alternatives><mixed-citation xml:lang="ru">Lin J., Xie J., Qian W.B. Telomerase activity and telomere length in CD4+, CD8+ and CD19+ lymphocytes from patients with systemic lupus erythematosus//Zhejiag Da Xue Bao Yi Xue Ban. -2005. -Vol. 34, N 6. -P. 534-537.</mixed-citation><mixed-citation xml:lang="en">Lin J., Xie J., Qian W.B. Telomerase activity and telomere length in CD4+, CD8+ and CD19+ lymphocytes from patients with systemic lupus erythematosus//Zhejiag Da Xue Bao Yi Xue Ban. -2005. -Vol. 34, N 6. -P. 534-537.</mixed-citation></citation-alternatives></ref><ref id="cit25"><label>25</label><citation-alternatives><mixed-citation xml:lang="ru">Lippi G., M. Franchini, G.L. Salavagno, G.C. Guidi Lipoprotein[a] and cancer: anti-neoplastic effect besides its cardiovascular poptency//Cancer Treatment Rev. -2007. -Vol. 33. -P. 427-436.</mixed-citation><mixed-citation xml:lang="en">Lippi G., M. Franchini, G.L. Salavagno, G.C. Guidi Lipoprotein[a] and cancer: anti-neoplastic effect besides its cardiovascular poptency//Cancer Treatment Rev. -2007. -Vol. 33. -P. 427-436.</mixed-citation></citation-alternatives></ref><ref id="cit26"><label>26</label><citation-alternatives><mixed-citation xml:lang="ru">Lund G., Andersson L., Lauria M., Lindholm M., Fragat M.F.,Villar-Garea A., Ballestar E., Esteller M., Zaina S. DNA methylation polymorhisms preccede any histological sign of atherosclerosis in mice lacking apolipoprotein E//J. Biol. Chemistry. -2004. -Vol. 279, N 28. -P. 29147-29154.</mixed-citation><mixed-citation xml:lang="en">Lund G., Andersson L., Lauria M., Lindholm M., Fragat M.F.,Villar-Garea A., Ballestar E., Esteller M., Zaina S. DNA methylation polymorhisms preccede any histological sign of atherosclerosis in mice lacking apolipoprotein E//J. Biol. Chemistry. -2004. -Vol. 279, N 28. -P. 29147-29154.</mixed-citation></citation-alternatives></ref><ref id="cit27"><label>27</label><citation-alternatives><mixed-citation xml:lang="ru">Lund G., Zaina S. Epigenetics, transgenerational effects and risk factors for atherosclerosis//Curr. Opin. Lipidol. -2009. Vol. 20, N 2. -P. 150-151.</mixed-citation><mixed-citation xml:lang="en">Lund G., Zaina S. Epigenetics, transgenerational effects and risk factors for atherosclerosis//Curr. Opin. Lipidol. -2009. Vol. 20, N 2. -P. 150-151.</mixed-citation></citation-alternatives></ref><ref id="cit28"><label>28</label><citation-alternatives><mixed-citation xml:lang="ru">Lyko F., Brown R. DNA methyltransferase inhibitors and the development of epigenetic cancer therapies//J. Natl. Cancer Inst. -2005. -Vol. 97, N 20. -P. 1498-1506.</mixed-citation><mixed-citation xml:lang="en">Lyko F., Brown R. DNA methyltransferase inhibitors and the development of epigenetic cancer therapies//J. Natl. Cancer Inst. -2005. -Vol. 97, N 20. -P. 1498-1506.</mixed-citation></citation-alternatives></ref><ref id="cit29"><label>29</label><citation-alternatives><mixed-citation xml:lang="ru">Marin M.L., Gordon R.E., Veith F.J., Tulchin N., Panetta T.F. Distribution of the c-myc oncoprotein in healthy and atherosclerotic human carotid arteries//Vasc. Surg. -1993. -Vol. 18, N 2. -P. 170-176.</mixed-citation><mixed-citation xml:lang="en">Marin M.L., Gordon R.E., Veith F.J., Tulchin N., Panetta T.F. Distribution of the c-myc oncoprotein in healthy and atherosclerotic human carotid arteries//Vasc. Surg. -1993. -Vol. 18, N 2. -P. 170-176.</mixed-citation></citation-alternatives></ref><ref id="cit30"><label>30</label><citation-alternatives><mixed-citation xml:lang="ru">Mattheews C., Gorenne I., Scott S., Figg N., Kirkpatrick P., Ritchie A., Goddard M., Bennett M. Vascular smooth muscle cells undergo telomere-based senescence in human atherosclerosis: effects of telomerase and oxidative stress//Circ. Res. -2006. -Vol. 99, N 2. -P. 156-164.</mixed-citation><mixed-citation xml:lang="en">Mattheews C., Gorenne I., Scott S., Figg N., Kirkpatrick P., Ritchie A., Goddard M., Bennett M. Vascular smooth muscle cells undergo telomere-based senescence in human atherosclerosis: effects of telomerase and oxidative stress//Circ. Res. -2006. -Vol. 99, N 2. -P. 156-164.</mixed-citation></citation-alternatives></ref><ref id="cit31"><label>31</label><citation-alternatives><mixed-citation xml:lang="ru">Minamoto T., Rjmuro I. Role of telomere in endothelial dysfunction in atherosclerosis//Curr Opin Lipidol. -2002. -Vol. 13, N 5. -P. 537-543.</mixed-citation><mixed-citation xml:lang="en">Minamoto T., Rjmuro I. Role of telomere in endothelial dysfunction in atherosclerosis//Curr Opin Lipidol. -2002. -Vol. 13, N 5. -P. 537-543.</mixed-citation></citation-alternatives></ref><ref id="cit32"><label>32</label><citation-alternatives><mixed-citation xml:lang="ru">Minev B., Hipp J., Firat H., Schmidt J.D., Langlade-Demoyen P., Zanetti M. Cytotoxic T cell immunity against telomerase reverse transcriptase in humans//Proc Natl Acad Sci U S A. -2000. -April 25. -Vol. 97(9). -P. 4796-4801.</mixed-citation><mixed-citation xml:lang="en">Minev B., Hipp J., Firat H., Schmidt J.D., Langlade-Demoyen P., Zanetti M. Cytotoxic T cell immunity against telomerase reverse transcriptase in humans//Proc Natl Acad Sci U S A. -2000. -April 25. -Vol. 97(9). -P. 4796-4801.</mixed-citation></citation-alternatives></ref><ref id="cit33"><label>33</label><citation-alternatives><mixed-citation xml:lang="ru">Miyamoto K., T.Ushijima Diagnostoc and therapeutic applications of epigenetics//Jpn. J. Oncol. -2005. -Vol. 35, N 6. -P. 293-301.</mixed-citation><mixed-citation xml:lang="en">Miyamoto K., T.Ushijima Diagnostoc and therapeutic applications of epigenetics//Jpn. J. Oncol. -2005. -Vol. 35, N 6. -P. 293-301.</mixed-citation></citation-alternatives></ref><ref id="cit34"><label>34</label><citation-alternatives><mixed-citation xml:lang="ru">Mund C., Brueckner B., Lyko F. Reactivation of epigenetically silenced genes by DNA methyltransferase inhibitors: basic concepts and clinical application//Epigenetics. -2006. -Vol. 1, N 1. -P. 7-13.</mixed-citation><mixed-citation xml:lang="en">Mund C., Brueckner B., Lyko F. Reactivation of epigenetically silenced genes by DNA methyltransferase inhibitors: basic concepts and clinical application//Epigenetics. -2006. -Vol. 1, N 1. -P. 7-13.</mixed-citation></citation-alternatives></ref><ref id="cit35"><label>35</label><citation-alternatives><mixed-citation xml:lang="ru">Naasani I., Seimiya H., Tsuruo T. Telomerase inhibition, telomere shortening, and senescence of cancer cells by tea catechins//Biochem Biophys Res Commun. -1998. -Vol. 249. -P. 391-396.</mixed-citation><mixed-citation xml:lang="en">Naasani I., Seimiya H., Tsuruo T. Telomerase inhibition, telomere shortening, and senescence of cancer cells by tea catechins//Biochem Biophys Res Commun. -1998. -Vol. 249. -P. 391-396.</mixed-citation></citation-alternatives></ref><ref id="cit36"><label>36</label><citation-alternatives><mixed-citation xml:lang="ru">Nair S.K., Heiser A., Boczkowski D., Majumdar A., Naoe M., Lebkowski J.S., Vieweg J., Gilboa E. Induction of cytotoxic T cell responses and tumor immunity against unrelated tumors using telomerase reverse transcriptase RNA transfected dendritic cells//Nature Medicine. -2000. -Vol. 6. -P. 1011-1017.</mixed-citation><mixed-citation xml:lang="en">Nair S.K., Heiser A., Boczkowski D., Majumdar A., Naoe M., Lebkowski J.S., Vieweg J., Gilboa E. Induction of cytotoxic T cell responses and tumor immunity against unrelated tumors using telomerase reverse transcriptase RNA transfected dendritic cells//Nature Medicine. -2000. -Vol. 6. -P. 1011-1017.</mixed-citation></citation-alternatives></ref><ref id="cit37"><label>37</label><citation-alternatives><mixed-citation xml:lang="ru">Nakamura T., Sekigawa I., Ogasawara H., Mitsuishi K., Hira K., Ikeda S., Ogawa H. Expression of DNMT-1 in patients with atopic dermatitis//Arch. Dermatol. Res. -2006. -Vol. 298, N 5. -P. 253-256.</mixed-citation><mixed-citation xml:lang="en">Nakamura T., Sekigawa I., Ogasawara H., Mitsuishi K., Hira K., Ikeda S., Ogawa H. Expression of DNMT-1 in patients with atopic dermatitis//Arch. Dermatol. Res. -2006. -Vol. 298, N 5. -P. 253-256.</mixed-citation></citation-alternatives></ref><ref id="cit38"><label>38</label><citation-alternatives><mixed-citation xml:lang="ru">Nurmohamed M.T., Dijkmans B.A.C. Dyslipidaemia, statins and rheumatoid arthritis//Ann Rheum Dis. -2009. -Vol. 68, N 4. -P. 453-455.</mixed-citation><mixed-citation xml:lang="en">Nurmohamed M.T., Dijkmans B.A.C. Dyslipidaemia, statins and rheumatoid arthritis//Ann Rheum Dis. -2009. -Vol. 68, N 4. -P. 453-455.</mixed-citation></citation-alternatives></ref><ref id="cit39"><label>39</label><citation-alternatives><mixed-citation xml:lang="ru">Pendino F., Tarkanyi I., Dudognon C., Hillion J., Lanotte M., Aradi J., Segal-Bendirdijan E. Telomeres and telomerase: pharmacological targets for new anticancer strategies?//Curr. Cancer Drug Targets. -2006. -Vol. 6, N 2. -P. 147-180.</mixed-citation><mixed-citation xml:lang="en">Pendino F., Tarkanyi I., Dudognon C., Hillion J., Lanotte M., Aradi J., Segal-Bendirdijan E. Telomeres and telomerase: pharmacological targets for new anticancer strategies?//Curr. Cancer Drug Targets. -2006. -Vol. 6, N 2. -P. 147-180.</mixed-citation></citation-alternatives></ref><ref id="cit40"><label>40</label><citation-alternatives><mixed-citation xml:lang="ru">Post W.S., Goldschmidt-Clermont P.J., Wihide C.C., Heldman A.W., Sussman M.S., Onyang P., Milliken E.E., Issa J.P. Methylation of the estrogen receptor gene is associated with a aging and atherosclerosis in the cardiovascular system//Cardiovasc. Res. -1999. -Vol. 43, N 4. -P. 985-991.</mixed-citation><mixed-citation xml:lang="en">Post W.S., Goldschmidt-Clermont P.J., Wihide C.C., Heldman A.W., Sussman M.S., Onyang P., Milliken E.E., Issa J.P. Methylation of the estrogen receptor gene is associated with a aging and atherosclerosis in the cardiovascular system//Cardiovasc. Res. -1999. -Vol. 43, N 4. -P. 985-991.</mixed-citation></citation-alternatives></ref><ref id="cit41"><label>41</label><citation-alternatives><mixed-citation xml:lang="ru">Rauch T., Wang Z., Zhang X., Zhong X., Wu X., Lau S.K., Kernistine K.H., Riggs A.D., Pfeifer G.P. Homeobox gene methylation in lung cancer studied by genome-wide analysis with a microarray-based methylated CgG island recovery assay//Proc. Natl. Acad. Sci. -2007. -Vol. 104, N 13. -P. 5527-5532.</mixed-citation><mixed-citation xml:lang="en">Rauch T., Wang Z., Zhang X., Zhong X., Wu X., Lau S.K., Kernistine K.H., Riggs A.D., Pfeifer G.P. Homeobox gene methylation in lung cancer studied by genome-wide analysis with a microarray-based methylated CgG island recovery assay//Proc. Natl. Acad. Sci. -2007. -Vol. 104, N 13. -P. 5527-5532.</mixed-citation></citation-alternatives></ref><ref id="cit42"><label>42</label><citation-alternatives><mixed-citation xml:lang="ru">Raynaud C.M., Sabatier L., Philipot O., Olaussen K.A., Soria J-C. Telomere length, telomeric proteins and genomic instability during the multistep carcinogenic process//Critical Rev in Oncol/Hematol. -2008. -Vol. 66, N 2. -P. 99-117.</mixed-citation><mixed-citation xml:lang="en">Raynaud C.M., Sabatier L., Philipot O., Olaussen K.A., Soria J-C. Telomere length, telomeric proteins and genomic instability during the multistep carcinogenic process//Critical Rev in Oncol/Hematol. -2008. -Vol. 66, N 2. -P. 99-117.</mixed-citation></citation-alternatives></ref><ref id="cit43"><label>43</label><citation-alternatives><mixed-citation xml:lang="ru">Samani N.J., Boultby R., Thompson J.R., Goodall A.H. Telomere shortening in atherosclerosis//Lancet. -2002. -Vol. 358, N 9280. -P. 472-473.</mixed-citation><mixed-citation xml:lang="en">Samani N.J., Boultby R., Thompson J.R., Goodall A.H. Telomere shortening in atherosclerosis//Lancet. -2002. -Vol. 358, N 9280. -P. 472-473.</mixed-citation></citation-alternatives></ref><ref id="cit44"><label>44</label><citation-alternatives><mixed-citation xml:lang="ru">Sano H., Compton L.J., Shiomi N., Steinberg A.D., Jackson R.A., Sasaki T. Low expression of human histocompatibility leukocyte antigen-DR is associated with hypermethylation of human histocompatibility leukocyte antigen-DR alpha gene regions in B cells from patients with systemic lupus erythematosus//J. Clin. Invest. -1985. -Vol. 76, N 4. -P. 1314-1322.</mixed-citation><mixed-citation xml:lang="en">Sano H., Compton L.J., Shiomi N., Steinberg A.D., Jackson R.A., Sasaki T. Low expression of human histocompatibility leukocyte antigen-DR is associated with hypermethylation of human histocompatibility leukocyte antigen-DR alpha gene regions in B cells from patients with systemic lupus erythematosus//J. Clin. Invest. -1985. -Vol. 76, N 4. -P. 1314-1322.</mixed-citation></citation-alternatives></ref><ref id="cit45"><label>45</label><citation-alternatives><mixed-citation xml:lang="ru">Scarano M.I., Strazzullo M., Matarazzo M.R., D'Esposito M. DNA methylation 40 years later: Its role in human health and disease//J. Cell. Physiol. -2005. -Vol. 204, N 1. -P. 21-35.</mixed-citation><mixed-citation xml:lang="en">Scarano M.I., Strazzullo M., Matarazzo M.R., D'Esposito M. DNA methylation 40 years later: Its role in human health and disease//J. Cell. Physiol. -2005. -Vol. 204, N 1. -P. 21-35.</mixed-citation></citation-alternatives></ref><ref id="cit46"><label>46</label><citation-alternatives><mixed-citation xml:lang="ru">Sekigawa I., Kawasaki M., Ogasawara H., Kaneda K., Kaneka H., Takasaki Y., Ogawa H. DNA methylation: its contribution to systemic lupus erythematosus//Clin. ExP. Med. -2006. -Vol. 6, N 3. -P. 99-100.</mixed-citation><mixed-citation xml:lang="en">Sekigawa I., Kawasaki M., Ogasawara H., Kaneda K., Kaneka H., Takasaki Y., Ogawa H. DNA methylation: its contribution to systemic lupus erythematosus//Clin. ExP. Med. -2006. -Vol. 6, N 3. -P. 99-100.</mixed-citation></citation-alternatives></ref><ref id="cit47"><label>47</label><citation-alternatives><mixed-citation xml:lang="ru">Shay J.W., Wright W.E. Mechanism-based combination telomerase inhibition therahy//Cancer Res. -2005. -Vol. 7, N 1. -P. 1-2.</mixed-citation><mixed-citation xml:lang="en">Shay J.W., Wright W.E. Mechanism-based combination telomerase inhibition therahy//Cancer Res. -2005. -Vol. 7, N 1. -P. 1-2.</mixed-citation></citation-alternatives></ref><ref id="cit48"><label>48</label><citation-alternatives><mixed-citation xml:lang="ru">Shen L., Toyoto M., Kondo Y., Lin E., Zhang L., Guo Y., Hernandes N.S., Chen X., Ahmed S.,</mixed-citation><mixed-citation xml:lang="en">Shen L., Toyoto M., Kondo Y., Lin E., Zhang L., Guo Y., Hernandes N.S., Chen X., Ahmed S.,</mixed-citation></citation-alternatives></ref><ref id="cit49"><label>49</label><citation-alternatives><mixed-citation xml:lang="ru">Konishi K., Hamilton S.R., Issa J.P. Intergrated genetics and epigenetics analysis identifies three different subclasses of colon cancer // Proc Soc Natl. Acad. Sci. - 2007. - Vol. 104, N 47. - P. 18654-18659. Shin J-S., Hong A., Solomon M.J., Lee C.S. The role of telomere and telomerase in the pathology of human cancer and aging // Pathology. - 2006. - Vol. 38, N 2. - P. 103-113.</mixed-citation><mixed-citation xml:lang="en">Konishi K., Hamilton S.R., Issa J.P. Intergrated genetics and epigenetics analysis identifies three different subclasses of colon cancer // Proc Soc Natl. Acad. Sci. - 2007. - Vol. 104, N 47. - P. 18654-18659. Shin J-S., Hong A., Solomon M.J., Lee C.S. The role of telomere and telomerase in the pathology of human cancer and aging // Pathology. - 2006. - Vol. 38, N 2. - P. 103-113.</mixed-citation></citation-alternatives></ref><ref id="cit50"><label>50</label><citation-alternatives><mixed-citation xml:lang="ru">Steer S.E., Williams F.M., Kato B., Gardner J.P., Norman P.J., Hall M.A., Kimura M., Vaughan R., Aviv A., Spector T.D. Reduced telomere length in rheumatoid arthritis is independent of disease activity and duration//Ann. Rheum. -2007. -Vol. 66, N 4. -P. 476-480.</mixed-citation><mixed-citation xml:lang="en">Steer S.E., Williams F.M., Kato B., Gardner J.P., Norman P.J., Hall M.A., Kimura M., Vaughan R., Aviv A., Spector T.D. Reduced telomere length in rheumatoid arthritis is independent of disease activity and duration//Ann. Rheum. -2007. -Vol. 66, N 4. -P. 476-480.</mixed-citation></citation-alternatives></ref><ref id="cit51"><label>51</label><citation-alternatives><mixed-citation xml:lang="ru">Sugino Y., Misawa A., Inone J., Kitagawa M., Hosoi H., Sugimoto T., Imoto I., Inazawa J. Epigenetic silencing of prostaglandin E receptor 2 (PTGER2) is associated with progression of neuroblastomas//Oncogene. -2007. -Vol. 26, N 53. -P. 7401-7413.</mixed-citation><mixed-citation xml:lang="en">Sugino Y., Misawa A., Inone J., Kitagawa M., Hosoi H., Sugimoto T., Imoto I., Inazawa J. Epigenetic silencing of prostaglandin E receptor 2 (PTGER2) is associated with progression of neuroblastomas//Oncogene. -2007. -Vol. 26, N 53. -P. 7401-7413.</mixed-citation></citation-alternatives></ref><ref id="cit52"><label>52</label><citation-alternatives><mixed-citation xml:lang="ru">Takami N., Osawa K., Miura Y., Komai K., Taniguchi M., Shiraishi M., Sato K., Iguchi T., Shiozawa K., Hashiramoto A., Shiozawa S. Hypermethylated promoter region of DR3, the death receptor 3 gene, in rheumatoid synovial cells//Arthritis Rheum. -2006. -Vol. 54, N 3. -P. 779-787.</mixed-citation><mixed-citation xml:lang="en">Takami N., Osawa K., Miura Y., Komai K., Taniguchi M., Shiraishi M., Sato K., Iguchi T., Shiozawa K., Hashiramoto A., Shiozawa S. Hypermethylated promoter region of DR3, the death receptor 3 gene, in rheumatoid synovial cells//Arthritis Rheum. -2006. -Vol. 54, N 3. -P. 779-787.</mixed-citation></citation-alternatives></ref><ref id="cit53"><label>53</label><citation-alternatives><mixed-citation xml:lang="ru">Van Vliet J., Oates N.A., Whitelaw E. Epigenetic mechanisms in the context of complex diseases//Cell. Mol. Life. -2007. -Vol. 64, N 12. -P. 1531-1538.</mixed-citation><mixed-citation xml:lang="en">Van Vliet J., Oates N.A., Whitelaw E. Epigenetic mechanisms in the context of complex diseases//Cell. Mol. Life. -2007. -Vol. 64, N 12. -P. 1531-1538.</mixed-citation></citation-alternatives></ref><ref id="cit54"><label>54</label><citation-alternatives><mixed-citation xml:lang="ru">Vivekanandan P., Thomas D., Torbenson M. Hepatitis B viral DNA is methylated in liver tissues//J. Viral Hepar. -2008. -Vol. 15, N 2. -P. 103-107.</mixed-citation><mixed-citation xml:lang="en">Vivekanandan P., Thomas D., Torbenson M. Hepatitis B viral DNA is methylated in liver tissues//J. Viral Hepar. -2008. -Vol. 15, N 2. -P. 103-107.</mixed-citation></citation-alternatives></ref><ref id="cit55"><label>55</label><citation-alternatives><mixed-citation xml:lang="ru">Waggoner D. Mechanisms of disease: epigenesist//Semin Pediatr Neural. -2007. -Vol. 14, N 1. -P. 7-14.</mixed-citation><mixed-citation xml:lang="en">Waggoner D. Mechanisms of disease: epigenesist//Semin Pediatr Neural. -2007. -Vol. 14, N 1. -P. 7-14.</mixed-citation></citation-alternatives></ref><ref id="cit56"><label>56</label><citation-alternatives><mixed-citation xml:lang="ru">Waterland R.A., Jirtle R.L. Transposable elements: targets for early nutritional effects on epigenetic gene regulation//Mol. Cell Biol. -2003. -Vol. 23, N 15. -P. 5293-5300.</mixed-citation><mixed-citation xml:lang="en">Waterland R.A., Jirtle R.L. Transposable elements: targets for early nutritional effects on epigenetic gene regulation//Mol. Cell Biol. -2003. -Vol. 23, N 15. -P. 5293-5300.</mixed-citation></citation-alternatives></ref><ref id="cit57"><label>57</label><citation-alternatives><mixed-citation xml:lang="ru">Wen Z.K., Xu W., Xu L., Cao Q.H., Wang Y., Chu Y.W., Xiong S.D. DNA hypomethylation is crucial for apoptotic DNA to unduce systemic lupus erythematosus-like autoimmune disease in SLE-non-susceptible mice//Rheumatology. -2007. -Vol. 46, N 12. -P. 1796-1803.</mixed-citation><mixed-citation xml:lang="en">Wen Z.K., Xu W., Xu L., Cao Q.H., Wang Y., Chu Y.W., Xiong S.D. DNA hypomethylation is crucial for apoptotic DNA to unduce systemic lupus erythematosus-like autoimmune disease in SLE-non-susceptible mice//Rheumatology. -2007. -Vol. 46, N 12. -P. 1796-1803.</mixed-citation></citation-alternatives></ref><ref id="cit58"><label>58</label><citation-alternatives><mixed-citation xml:lang="ru">Wilson M.J., Shivapukar N., Poirier L.A. Hypomethylation of hepatic nuclear DNA in rats fed with a carcinogenic methyl-deficient diet//Biochem J. -1984. -Vol. 218, N 3. -P. 987-990.</mixed-citation><mixed-citation xml:lang="en">Wilson M.J., Shivapukar N., Poirier L.A. Hypomethylation of hepatic nuclear DNA in rats fed with a carcinogenic methyl-deficient diet//Biochem J. -1984. -Vol. 218, N 3. -P. 987-990.</mixed-citation></citation-alternatives></ref><ref id="cit59"><label>59</label><citation-alternatives><mixed-citation xml:lang="ru">Ying A.K., Hassanain H.H., Ross C.M., Smiraglia D.J., Issa J.J., Michler R.E., Caligiuri M., Plass C., Goldschmidt-Clermot P.J. Methylation of the estrogen receptor-alpha gene promotor is selectivelly increased in proliferating human aortoc smooth muscle cells//Cardiovasc. Res. -2000. -Vol. 46, N 1. -P. 173-179.</mixed-citation><mixed-citation xml:lang="en">Ying A.K., Hassanain H.H., Ross C.M., Smiraglia D.J., Issa J.J., Michler R.E., Caligiuri M., Plass C., Goldschmidt-Clermot P.J. Methylation of the estrogen receptor-alpha gene promotor is selectivelly increased in proliferating human aortoc smooth muscle cells//Cardiovasc. Res. -2000. -Vol. 46, N 1. -P. 173-179.</mixed-citation></citation-alternatives></ref><ref id="cit60"><label>60</label><citation-alternatives><mixed-citation xml:lang="ru">Yoder J.A., Walsh C.P., Bertor T.H. Cytosine methylation and the ecology of intragenomic parasites//Trends Genet. -1997. -Vol. 13, N 8. -P. 335-340.</mixed-citation><mixed-citation xml:lang="en">Yoder J.A., Walsh C.P., Bertor T.H. Cytosine methylation and the ecology of intragenomic parasites//Trends Genet. -1997. -Vol. 13, N 8. -P. 335-340.</mixed-citation></citation-alternatives></ref></ref-list><fn-group><fn fn-type="conflict"><p>The authors declare that there are no conflicts of interest present.</p></fn></fn-group></back></article>
